Priaxon AG
Innovating Next-Generation Small Molecule Therapeutics with Unmatched Precision for Rapid Evaluation and Exploitation of New Drug Targets.
General Information
BounceWatch is an independent company data service, not affiliated with Priaxon AG. To contact Priaxon AG, visit priaxon.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Priaxon AG compare?
A PDF of Priaxon AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Priaxon AG soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Priaxon AG
Business keywords: Small molecule therapeutics, Drug discovery, Chemo-informatics, Molecular determinants, New target-ligand interactions, Rapid evaluation, NCE-based exploitation, Innovation efficiency, R&D economics, Precision medicine, Biopharmaceuticals, Chemical space exploration
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 |
|
29 May 2008 |
Priaxon AG Alternatives & Competitors
View All Alternatives
We’re driven to translate the most compelling and still undrugged targets in human biology into med...
Biotech leveraging AI, physics, and chemistry to design novel drugs against attractive targets.
Drugging the undruggable targets
FAQ About Priaxon AG
Source: BounceWatch company record for Priaxon AG, https://bouncewatch.com/company/priaxon-ag, updated 12 September 2024. When citing, please name BounceWatch and link this page.
